Disclosure Panels Details Page
Central Nervous System Cancers Panel - Disclosures as of 07/24/2017
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Joachim Baehring MD | Bristol Myers Squibb | Novocure | Bristol Myers Squibb | None | ✔ |
| Tracy Batchelor MD | NA | NA | NA | NA | - |
| Mary Anne Bergman | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Henry Brem MD | Johns Hopkins University | Acceluating Combination Therapies, LLC Acuity Bio Corp. AsclepiX Therapeutics, LLC Camden Partners Celsion-EGEN LikeMinds, Inc. Perosphere Inc. StemGen |
None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | - |
| Nicholas Butowski MD | Abbott Laboratories Bristol Myers Squibb Genentech, Inc. Omniox Pfizer Inc. |
Roche Laboratories, Inc. | Genentech, Inc. | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Anita Engh PhD | None | None | None | None | - |
| Peter Forsyth MD | None | AbbVie, Inc. Bristol Myers Squibb Novocure Ziopharm |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jona Hattangadi-Gluth MD | Varian Medical Systems, Inc. | None | None | None | ✔ |
| Matthias Holdhoff MD, PhD | None | A law firm in Louisiana; I provided advice | Cavion | None | ✔ |
| Steven Howard MD | None | None | None | None | ✔ |
| Larry Junck MD | Immunocellular Therapeutics Northwest Biotherapeutics, Inc. PRA Healthsciences Tocagen VBL Therapeutics |
Tocagen | None | None | ✔ |
| Thomas Kaley MD | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Priya Kumthekar MD | AbbVie, Inc. Angiochem Genentech, Inc. Novocure Orbus therapeutics VBL therapeutics |
AbbVie, Inc. Angiochem |
None | None | ✔ |
| Jay Loeffler MD | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Paul Moots MD | ECOG | None | None | None | ✔ |
| Maciej Mrugala MD, PhD, MPH | NA | NA | NA | NA | ✔ |
| Louis Nabors MD | Bristol Myers Squibb Merck & Co., Inc. Tocagen Univ Penn Ziopharm |
Merck & Co., Inc. Tocagen |
Merck & Co., Inc. | None | ✔ |
| Seema Nagpal MD | Berg Health Nektar Therapeutics Regeneron Tocagen Vascular Biogenics |
Novocure | None | None | ✔ |
| Manjari Pandey MD | None | None | None | None | ✔ |
| Ian Parney MD, PhD | None | None | None | None | ✔ |
| Katherine Peters MD, PhD, FAAN | Agios, Inc. Biomimetix Eisai Inc. Genentech, Inc. Merck & Co., Inc. VBL |
AbbVie, Inc. Agios, Inc. Novocure |
None | None | ✔ |
| Jana Portnow MD | Eisai Inc. Eli Lilly and Company Kadmon |
None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Dheerendra Prasad MD, FACRO | None | EAB, Stockholm, Sweden Elekta Inc. Atlanta GA |
None | None | - |
| Vinay Puduvalli MD | NA | NA | NA | NA | ✔ |
| John Ragsdale III MD | NA | NA | NA | NA | ✔ |
| Jason Rockhill MD, PhD | None | None | None | None | ✔ |
| Lisa Rogers DO | None | None | None | None | ✔ |
| Chad Rusthoven MD | None | None | None | None | ✔ |
| Nicole Shonka MD | None | None | None | None | ✔ |
| Dennis Shrieve MD, PhD | None | None | None | None | ✔ |
| Allen Sills MD | Head Sense | National Football League | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Lode Swinnen MBChB | Abbott Laboratories Johns Hopkins University Pharmacyclics |
None | Pharmacyclics | None | ✔ |
| Christina Tsien MD | None | None | Merck & Co., Inc. | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Stephanie Weiss MD | None | None | None | None | ✔ |
| Patrick Wen MD | Acerta Pharma Agios, Inc. Angiochem Inc AstraZeneca Pharmaceuticals LP Genentech, Inc. GSK Karyopharm Therapeutics, Inc Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncoceutics Inc sanofi-aventis U.S. Vascular Biogenics |
Agios, Inc. AstraZeneca Pharmaceuticals LP Cavion Pharma Cortice Biosciences Foundation Medicine Genentech, Inc. Insys Therapeutics Monteris Novocure ORIC Pharma Vascular Biogenics |
Merck & Co., Inc. | None | ✔ |
| Nicole Willmarth PhD | None | None | None | None | ✔ |